Cygnusbio is a company headquartered in China.
Cygnusbio develops and manufactures genetic sequencing instruments, reagents, and genetic testing products for various disease risk assessments and personalized medicine, leveraging their proprietary sequencing technologies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.